GlassScriptPhysician profile
Daniel J Cosgrove
NPI 1790766491
$6,957.33
in general payments reported to CMS, 2019-2025
46 companies · $1,087 in 2025
The $1,087 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $670 · 2020: $1,670 · 2021: $563 · 2022: $925 · 2023: $970 · 2024: $1,073 · 2025: $1,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,015 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,014.99 |
| Education | $114.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $1,305.81 | 2020 | |
| Abbvie INC. | $930.64 | 2019-2025 | Botox, Lupron Depot |
| Endo Pharmaceuticals INC. | $524.44 | 2019-2024 | Xiaflex, Aveed |
| Allergan, INC. | $398.62 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $360.91 | 2021-2025 | Prolaris, Myrisk |
| Pfizer INC. | $305.50 | 2019-2025 | |
| Blue Earth Diagnostics | $278.37 | 2020-2025 | Posluma |
| Progenics Pharmaceuticals, INC. | $273.29 | 2021-2025 | Pylarify |
| Antares Pharma, INC. | $200.43 | 2019-2024 | Xyosted, Tlando, Nocdurna |
| Procept Biorobotics Corporation | $187.50 | 2021-2022 | |
| Coloplast Corp | $153.43 | 2019-2024 | Titan |
| Janssen Biotech, INC. | $138.26 | 2021-2025 | Erleada |
| Astellas Pharma US INC | $137.67 | 2019-2021 | |
| Endo USA, INC. | $127.42 | 2024-2025 | Xiaflex, Aveed |
| Boston Scientific Corporation | $125.95 | 2019-2024 | Ams 700, Rezum Generator |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $119.02 | 2019-2025 | Adstiladrin |
| 180 Medical, INC. | $115.73 | 2019-2024 | Bardex I.C. Tiemann Model Coude Tip Foley Catheter |
| Sumitomo Pharma America, INC. | $89.73 | 2023-2025 | Gemtesa, Orgovyx |
| Cleerly, INC. | $79.89 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Azurity Pharmaceuticals, INC. | $73.53 | 2025 | Azmiro |
| Dendreon Pharmaceuticals LLC | $73.10 | 2019-2023 | Provenge |
| Kerecis Limited | $70.97 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Immunitybio, INC. | $68.25 | 2025 | |
| Myovant Sciences INC. | $60.86 | 2021-2022 | |
| Tolmar, INC. | $59.73 | 2023 | |
| Novartis Pharmaceuticals Corporation | $56.46 | 2025 | |
| Seagen INC. | $54.99 | 2025 | |
| Teleflex LLC | $51.22 | 2025 | Barrigel |
| Laborie Medical Technologies Corp. | $48.40 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Olympus America INC. | $48.33 | 2020-2023 | Itind System |
| Convatec INC. | $45.27 | 2022-2023 | |
| Clarus Therapeutics INC. | $40.33 | 2021 | |
| Becton, Dickinson and Company | $31.81 | 2024 | Bard Urinary Drainage Bag |
| Bayer Healthcare Pharmaceuticals INC. | $31.41 | 2024 | |
| Acerus Pharmaceuticals Corporation | $30.95 | 2020 | |
| Urogen Pharma, INC. | $30.71 | 2025 | |
| Abc Home Medical Supply, INC. | $28.68 | 2023 | |
| Profound Medical Corp. | $26.72 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $26.42 | 2023 | Bard Urinary Drainage Bag |
| Zyla Life Sciences, INC. | $26.26 | 2019 | |
| Halozyme INC | $24.73 | 2023 | |
| Metuchen Pharmaceuticals | $24.13 | 2019 | |
| Dentsply Ih Ab | $18.49 | 2025 | Lofric |
| Aytu Biopharma, INC. | $18.38 | 2019 | |
| Merck Sharp & Dohme LLC | $17.66 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $16.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Cosgrove listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.